Eventide Asset Management - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2021$38,397,000
-14.9%
578,0000.0%0.51%
-16.5%
Q2 2021$45,096,000
-5.6%
578,000
+14.5%
0.61%
-14.4%
Q1 2021$47,768,000
-32.8%
505,000
-13.4%
0.71%
-35.0%
Q4 2020$71,039,000
+112.3%
583,000
+52.2%
1.09%
+66.3%
Q3 2020$33,459,000
+35.3%
383,0000.0%0.66%
+21.7%
Q2 2020$24,738,000383,0000.54%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q2 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,392,297$291,501,0006.94%
Burrage Capital Management LLC 72,484$8,832,0006.73%
MPM BioImpact LLC 617,372$75,226,0006.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 113,541$13,816,0003.77%
Orbimed Advisors 2,745,327$334,518,0002.93%
SECTORAL ASSET MANAGEMENT INC 257,379$31,362,0002.21%
Parkman Healthcare Partners LLC 59,377$7,235,0001.85%
Nicholas Investment Partners, LP 183,676$22,381,0001.73%
EMERALD ADVISERS, LLC 357,038$43,505,0001.44%
EMERALD MUTUAL FUND ADVISERS TRUST 336,173$40,963,0001.42%
View complete list of TURNING POINT THERAPEUTICS I shareholders